Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KIR2DL5/CD158f Antibody (UP-R1), DyLight 350, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP262222UV

Catalog No. NB002791


Only null left
Add to Cart

Description

Description

KIR2DL5/CD158f Monoclonal specifically detects KIR2DL5/CD158f in Human samples. It is validated for Flow Cytometry, Immunocytochemistry.
Specifications

Specifications

KIR2DL5/CD158f
Monoclonal
DyLight 350
50mM Sodium Borate with 0.05% Sodium Azide
KIR2DL5A
Human CD158f-Ig fusion protein
0.1 mL
Primary
The antibody MEM-59 recognizes neuraminidase-sensitive epitope on CD43 (Leukosialin), a 95-135 kDa type I transmembrane glycoprotein (mucin-type) which is involved in lymphocyte activation. CD43 is expressed by platelets and at high levels on the surface of all leukocytes; it is negative on resting B lymphocytes and erythrocytes.
Store at 4°C in the dark.
Flow Cytometry, Immunocytochemistry
UP-R1
Flow Cytometry, Immunocytochemistry
CD158F, CD158F1, killer cell immunoglobulin-like receptor 2DL5A, killer cell immunoglobulin-like receptor KIR2DL5A, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A, killer-cell Ig-like receptor, KIR2DL5, KIR2DL5.1, KIR2DL5.3, KIR2DL5B
Mouse
Protein A purified
Immunology
57292
Human
IgG1 κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.